Other priority projects are in development. AMN107 is an investigational oral compound being studied in the small subset of advanced chronic myeloid leukemia patients who do not respond or stop responding to Gleevec/Glivec and have no treatment options available. Phase II trials for the compound are expected to start in the first half of 2005.
 


New! Sign up for local CML support group meetings in your local community at http://cml.meetup.com

Apply for Commercial Real Estate loans online and submit your deal to dozens of hungry lenders in just minutes. Loan programs for all types of business and commercial real estate. Apply anytime at http://realestatezoo.com

CML (Chronic Myelogenous Leukemia Support List)
---------------------------------
Part Of CMLHope.Com
An International Community Of CML Patients
For more information: http://cmlhope.com

Post Message: [email protected]
Subscribe:  [EMAIL PROTECTED]
Unsubscribe:  [EMAIL PROTECTED]
Change To No Mail/Web: [EMAIL PROTECTED]
Change To Digest: [EMAIL PROTECTED]
Change To Email: [EMAIL PROTECTED]
List Help: [EMAIL PROTECTED] 
CML Group Web Site http://groups.yahoo.com/group/CML



Yahoo! Groups Sponsor
ADVERTISEMENT
click here


Yahoo! Groups Links

Reply via email to